Canopy Growth Corporation

NASDAQ:CGC

Drug Manufacturers - Specialty & Generic

Healthcare
$0.50 +1.07%

+$0.01 today

Market cap
$212.31M
Beta
0.78
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $0.84High $2.38

Volume 3.44M

Average 9.97M

CGC Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Canopy Growth CorporationNASDAQ: CGC

Retained Earnings · Q4 FY2025 · quarter ended Mar 2026

Retained earnings remains negative

Q4 FY2025 retained earnings was -CA$11.14B, compared with -CA$10.93B a year earlier.

Context

  • Retained earnings amounted to 995.6% of total assets at the end of Q4 FY2025, down 195.2 pp from a year earlier.
  • Retained earnings grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether retained earnings keeps falling in the next quarterly balance sheet after a -1.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$11.14B+26.4% QoQ
Last fiscal yearMar 2026
-CA$11.14B-1.9% YoY
Year agoMar 2025
-CA$10.93B-1.9% since
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.9%——
1 year-1.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

CAD · from the balance sheet

Latest · FY2025
(11.14B) CAD
Year-over-year change
-1.9%

Retained Earnings vs competitors

How CGC compares with its peers on the latest reported figures

  • Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -1.9% is the 2nd highest of 9, against a peer median of -15.8%.
  • Retained earnings amounts to 995.6% of total assets for CGC, versus a peer median of 375.8%.
CGC Competitors
Retained Earnings for CGC and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TKNOAlpha Teknova, Inc.Mar 2026-$140.35M USD-13.9%—142.3%
LFCRLifecore Biomedical, Inc.Dec 2025-$223.2M USD——96.1%
BIOABioAge Labs, Inc.Mar 2026-$355.67M USD-33.8%—89.4%
CABACabaletta Bio, Inc.Mar 2026-$560.47M USD-45.6%—378.3%
DHDefinitive Healthcare Corp.Mar 2026-$918.13M USD-22.8%—178.4%
ACRSAclaris Therapeutics, Inc.Mar 2026-$987.61M USD-7.6%—497.0%
IRWDIronwood Pharmaceuticals, Inc.Mar 2026-$1.63B USD+5.9%—375.8%
LYELLyell Immunopharma, Inc.Mar 2026-$1.64B USD-17.6%—468.8%
ACBAurora Cannabis Inc.Mar 2026-CA$6.46B CAD-2.0%—1071.7%
CGCCanopy Growth CorporationMar 2026-CA$11.14B CAD-1.9%—995.6%
Peer median (excluding CGC) —-15.8%—375.8%

Competitors are the stored peer set for CGC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Cash & Equivalents776.01M667.69M170.3M113.81M508.58M
Short-term Investments595.65M105.53M33.16M17.66M5.06M
Net Receivables86.58M68.46M51.85M52.78M36.29M
Inventory204.54M83.23M77.29M96.37M154.12M
Other Current Assets31.28M138.17M29.59M8.44M39.39M
Total Current Assets1.73B1.08B371.18M294.57M738.38M
Property, Plant & Equipment (Net)942.78M471.27M320.1M293.52M441.37M
Goodwill1.87B85.56M43.24M46.04M77.66M
Intangible Assets252.7M160.75M104.05M87.2M128.87M
Long-term Investments341.73M568.29M136.22M35.29M150.63M
Tax Assets00000
Other Non-current Assets473.94M76.57M325.53M161.07M23.24M
Total Non-current Assets3.88B1.36B929.15M623.13M821.77M
Total Assets5.61B2.44B1.3B917.7M1.56B
Account Payables64.27M31.84M28.67M26.1M34.82M
Short-term Debt9.3M556.89M103.94M4.26M22.64M
Tax Payables7.14M5.73M10.52M13.07M0
Deferred Revenue005.85M00
Other Current Liabilities76.71M175M53.77M31.73M134.77M
Total Current Liabilities213.19M803.84M234.72M94.4M220.96M
Long-term Debt1.49B749.99M493.29M299.81M302.79M
Deferred Tax Liabilities15.99M357K0011.43M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities162.84M47.12M16.22M8.49M6.35M
Total Non-current Liabilities1.77B875.83M565.11M336.08M366.35M
Total Liabilities1.98B1.68B799.82M430.49M587.31M
Common Stock7.48B7.94B8.24B8.8B9.23B
Retained Earnings(6.38B)(9.67B)(10.33B)(10.93B)(11.14B)
Accumulated OCI(42.28M)(13.86M)(16.05M)535K10.53M
Other Stockholders Equity00000
Minority Interest36.84M1.59M139K00
Total Equity3.62B760.02M500.51M487.21M972.84M
Total Debt1.64B1.41B668M348.4M325.44M
Net Debt864.15M745.98M497.7M234.59M(183.14M)

Canopy Growth Corporation

NASDAQ:CGC

Intrinsic Alpha fair value

Locked

Current Price

$0.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.